CHLOROGENIC ACID AMELIORATES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN MICE: POTENTIAL PHARMACOTHERAPEUTIC APPLICATION IN MULTIPLE SCLEROSIS

CHLOROGENIC ACID AMELIORATES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN MICE: POTENTIAL PHARMACOTHERAPEUTIC APPLICATION IN MULTIPLE SCLEROSIS

Bibliographic Details
Main Authors:	Sohi Kang, Sungmoo Hong, Joong-Sun Kim, Changjong Moon, Taekyun Shin
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123005481

Similar Items

Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
by: Sungmoo Hong, et al.
Published: (2024-12-01)

Transcriptome Profiling in the Hippocampi of Mice with Experimental Autoimmune Encephalomyelitis
by: Poornima D. E. Weerasinghe-Mudiyanselage, et al.
Published: (2022-11-01)

Retinal transcriptome profiling identifies novel candidate genes associated with visual impairment in a mouse model of multiple sclerosis
by: Sungmoo Hong, et al.
Published: (2023-12-01)

Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis
by: Melissa Tully, et al.
Published: (2018-06-01)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
by: Amy Lovett-Racke, et al.
Published: (2022-11-01)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
by: Jean Pierre Pallais, et al.
Published: (2020-01-01)

Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
by: Cervellini, I, et al.
Published: (2013)

Therapeutic efficacy of erythrpoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis
by: Cervellini, I, et al.
Published: (2013)

Amelioration of experimental autoimmune encephalomyelitis by anatabine.
by: Daniel Paris, et al.
Published: (2013-01-01)

Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model
by: David Baker, et al.
Published: (2019-08-01)

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
by: K. Schmitz, et al.
Published: (2017-06-01)

A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.
by: Jagodic, M, et al.
Published: (2009)

Role of Peripheral Immune Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Sarah Dhaiban, et al.
Published: (2021-02-01)

Oral Administration of Probiotic Enterococcus durans to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice
by: Seyed Abdollah Samani, et al.
Published: (2022-01-01)

Galangin ameliorates experimental autoimmune encephalomyelitis in mice via modulation of cellular immunity
by: Kok-Tong Tan, et al.
Published: (2021-01-01)

Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
by: Susanta Mondal, et al.
Published: (2015-01-01)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
by: Leonie Stolz, et al.
Published: (2017-07-01)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
by: Marina Boziki, et al.
Published: (2023-01-01)

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: James L. Quinn, et al.
Published: (2018-10-01)

Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
by: Yuan Yue, et al.
Published: (2018-01-01)

Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
by: Thomas W Johnson, et al.
Published: (2016-01-01)

Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis
by: Gabriel eArellano, et al.
Published: (2015-09-01)

Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis
by: Blankenhorn Elizabeth P, et al.
Published: (2006-09-01)

Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis
by: Damien D Pearse, et al.
Published: (2022-01-01)

TGF-β in Mice Ameliorates Experimental Autoimmune Encephalomyelitis in Regulating NK Cell Activity
by: J. Xu, et al.
Published: (2019-09-01)

Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis
by: Goran Stegnjaić, et al.
Published: (2022-12-01)

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
by: Müller André, et al.
Published: (2012-03-01)

Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis
by: Zhaolan Hu, et al.
Published: (2018-07-01)

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
by: Alba Sánchez-Fernández, et al.
Published: (2022-02-01)

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
by: Kaili Lu, et al.
Published: (2020-02-01)

Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions
by: Dain L. Maxwell, et al.
Published: (2023-10-01)

Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis
by: Rhonda R. Voskuhl, et al.
Published: (2022-10-01)

Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis
by: Martin M. Herrmann, et al.
Published: (2016-10-01)

Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis
by: Nathalia Bernardes Teixeira, et al.
Published: (2020-09-01)

Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
by: Yuying Fan, et al.
Published: (2019-04-01)

The Kappa Opioid Receptor: Candidate Pharmacotherapeutic Target for Multiple Sclerosis
by: Brian Reed, et al.
Published: (2023-11-01)

Behavioral investigation of mice with experimental autoimmune encephalomyelitis
by: David Henrique Rodrigues, et al.
Published: (2011-12-01)

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.
by: Pomeroy, I, et al.
Published: (2005)

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.
by: Pomeroy, I, et al.
Published: (2005)

Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis
by: Esther Melamed, et al.
Published: (2022-11-01)